• Fluorouracil and Wnt: A Translational Playbook

  2026-09-11

  Fluorouracil is more than a viability benchmark. This thought-leadership guide connects its thymidylate synthase mechanism with Wnt-driven tumor biology, immune context, experimental design, and translational decision-making in solid tumor research.

• Nuclear mTORC1 Control Revealed by TerminaTOR

  2026-09-11

  The reference study introduces TerminaTOR, a genetically encodable inhibitor that can suppress mTORC1 selectively at defined subcellular locations. By separating lysosomal from nuclear mTORC1 activity, the authors show that nuclear mTORC1 regulates transcription of genes containing CCAAT motifs, extending mTORC1 biology beyond its canonical metabolic and translational functions.

• Isorhamnetin N1358: Reliable Cell Assays

  2026-09-10

  This scenario-based guide explains how Isorhamnetin (SKU N1358) can improve experimental control in cell viability, proliferation, apoptosis, and oxidative stress workflows. It connects formulation, dose selection, controls, and mechanistic interpretation to published oocyte-maturation data and practical laboratory decision-making.

• D-Lin-MC3-DMA: Ionizable Cationic Liposome

  2026-09-10

  Dlin-MC3-DMA is an ionizable cationic liposome lipid for LNP-based siRNA delivery and mRNA vaccine formulation. Reported product and peer-reviewed evidence connect MC3 with potent hepatic gene silencing, endosomal escape, and data-guided optimization of RNA delivery systems.

• Dlin-MC3-DMA for Smarter RNA-LNP Design

  2026-09-09

  Dlin-MC3-DMA is an ionizable cationic liposome lipid for potent siRNA and mRNA delivery. This article explains how a 2025 machine-learning study shifts LNP development from carrier potency alone toward cell-state-aware assay design, with practical guidance for hepatic and microglial research.

• BI 2536: PLK1 Inhibitor Workflow Guide

  2026-09-09

  BI 2536 combines subnanomolar PLK1 inhibition with practical readouts for mitotic arrest, checkpoint regulation, and apoptosis. This guide connects cell-based dose–response experiments with mechanistic MCC-disassembly assays and tumor xenograft interpretation.

• WSP-5 for Live-Cell H2S Imaging

  2026-09-08

  WSP-5 converts hydrogen sulfide reactivity into a rapid, turn-on fluorescence signal for live-cell experiments, donor-release studies, and disease modeling. This guide translates diabetic cardiomyopathy findings into practical assay design, controls, optimization steps, and troubleshooting decisions.

• RNA Clean and Concentrator Kit for IRES Assays

  2026-09-07

  The RNA Clean and Concentrator Kit supports controlled RNA purification from enzymatic reactions, with particular value for IRES-focused antiviral assays. This guide explains how cleanup chemistry influences mechanistic interpretation, assay controls, and reproducibility beyond routine spin-column use.

• HyperScribe™ T7 High Yield RNA Synthesis Kit Plus

  2026-09-07

  A scenario-driven guide to using HyperScribe™ T7 High Yield RNA Synthesis Kit Plus (SKU K1401) for reproducible RNA inputs in cell viability, proliferation, and cytotoxicity studies. It connects T7 transcription principles with FLCN mRNA rescue evidence, practical optimization, data interpretation, and vendor selection.

• TRPV1 and TRPA1 Control of TSLP in Nasal Epithelium

  2026-09-05

  The reference study identifies a calcium-dependent TRPV1/TRPA1–NFAT pathway linking environmental sensing at nasal epithelial cells to production of the inflammatory cytokine TSLP. Its combined use of imaging, pharmacological perturbation, gene silencing, calcium chelation, and cytokine analysis provides a useful framework for studying epithelial contributions to upper-airway inflammation.

• Machine Learning Predicts mRNA Vaccine LNPs

  2026-09-05

  Wang and colleagues developed a LightGBM model to predict lipid nanoparticle formulations for mRNA vaccines from 325 formulation samples and reported an R² value above 0.87. Experimental comparison of MC3 and SM-102, together with molecular dynamics modeling, linked computational prediction to vaccine performance and LNP assembly.

• PAGL Airway Stent Suppresses Tracheal Restenosis

  2026-09-04

  Zhao et al. developed PAGL, an electrospun airway stent incorporating anlotinib hydrochloride and silver nanoparticles to address infection, inflammation, angiogenesis, and fibroblast activation in tracheal in-stent restenosis. In rabbit and in vitro models, PAGL improved local biological control and altered gene expression linked to fibrosis, intimal hyperplasia, and cell migration, supporting a multifunctional strategy for preclinical airway-stent design.

• BIBR 1532 Telomerase Inhibitor Workflow

  2026-09-04

  BIBR 1532 enables mechanism-focused studies of hTERT suppression, telomerase activity, telomere attrition, and apoptosis. This practical guide connects acute molecular assays with longer-term cancer cell proliferation inhibition and shows how to interpret combination experiments without confusing DNA-damage signals with direct telomerase effects.

• Eicosapentaenoic Acid: Applied Research Workflows

  2026-09-03

  Eicosapentaenoic Acid (EPA) supports distinct cardiovascular research workflows spanning membrane remodeling, endothelial cell migration inhibition, and lipoprotein oxidation assays. This practical guide shows how to use a characterized EPA omega-3 fatty acid preparation while avoiding oxidation, vehicle, and cross-domain interpretation errors.

• BAPTA for Calcium Signaling and Apoptosis

  2026-09-02

  BAPTA provides a practical way to test whether free Ca2+ is a causal driver of toxicant-induced cell death rather than a bystander signal. This workflow translates IP3R/Ca2+/STAT3 findings into controlled apoptosis research, calcium signaling modulation, and cell-based assay optimization.

8690 records 1/580 page Next 12345 下5页 Last page